Overview

A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
An open-label, single-dose study to investigate the pharmacokinetics of ACT-1014-6470 in subjects with severe renal impairment compared to control subjects
Phase:
Phase 1
Details
Lead Sponsor:
Idorsia Pharmaceuticals Ltd.